The Victoria’s Secret Global Fund for Women's Cancers was established to accelerate innovation in cancer research for women, by women. This groundbreaking initiative will fund innovative research aimed at progressing outcomes for women's cancers and invest in the next generation of women scientists who represent the diverse population they serve. By focusing on prevention, detection, diagnostic, and treatment innovations for women’s cancers and advancing outcomes for cancer health disparities, Victoria’s Secret aims to improve and save the lives of millions of women around the world.
The Fund builds upon Victoria's Secret’s established commitment toward cancer research and education, with longstanding impact partner, Pelotonia. Through a transformational partnership with Pelotonia and the American Association for Cancer Research (AACR), The Victoria’s Secret Global Fund for Women's Cancers is proud to offer a series of grants programs for female researchers and clinicians working internationally, and at various stages of their careers. To learn more please visit pelotonia.org/vsfund.
The Victoria’s Secret Global Fund for Women’s Cancers Rising Innovator Research Grant, in Partnership with Pelotonia & AACR, is intended to fund innovative research projects in breast and gynecologic cancers and to invest in female scientists at the Associate Professor level domestically and globally to foster innovation in the understanding, prevention, interception, early detection, diagnosis, and treatment of these cancers with the goal of eliminating cancer health disparities and improving patient outcomes. Proposed projects may be in basic, translational, clinical, or population sciences. Proposals focused on research into the causes of cancer health disparities and approaches to achieve equity in outcomes as well as applicants belonging to racial or ethnic groups shown to be underrepresented in the cancer-related sciences workforce* are especially encouraged (AACR Cancer Disparities Progress Report 2024).
Applicants must be female investigators with a doctoral degree (PhD, MD, MD/PhD, or equivalent) in a related field and not currently be a candidate for a further doctoral degree. Applicants must also have received their first NIH R01 (or equivalent) award within the past 10 years (i.e., grant cannot have been awarded before September 1, 2015).
An exception to the 10-year window may be granted for parental leave or other well-justified leave from research for pressing personal or family situations of generally less than 12 months’ duration. Applicants whose experience exceeds the maximum of 10 years but who believe they are eligible should contact the AACR’s RGA before submitting an application to verify their eligibility.
For the purpose of this grant, an R01 equivalent grant is defined as a grant that offers at least $250,000 (direct costs) per year for more than three years and must have undergone a peer-review process by active researchers and physician-scientists.
Applicants belonging to racial or ethnic groups shown to be underrepresented in the cancer-related sciences workforce* are especially encouraged to apply.
*For U.S. applicants, these groups include Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Native Hawaiians and other Pacific Islanders. For international applicants, these groups include citizens or permanent residents of countries building cancer research capacities (AACR Eligible Country List) who currently reside in one of those countries. Individual demographic information must be provided during application.
At the start of the grant term on September 1, 2025, applicants must:
Sponsor Institute/Organizations: Victoria’s Secret, Pelotonia & AACR,
Address: USA
Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.
Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.
Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.
Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.
Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.
Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.
Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.
Jan 23, 2025
Apr 24, 2025
$700,000
Affiliation: Victoria’s Secret, Pelotonia & AACR,
Address: USA
Disclaimer:It is mandatory that all applicants carry workplace liability insurance, e.g., https://www.protrip-world-liability.com (Erasmus students use this package and typically costs around 5 € per month - please check) in addition to health insurance when you join any of the onsite Trialect partnered fellowships.